H5N1 Viruses and Vaccines

This publication has 32 references indexed in Scilit:

• Newcastle Disease Virus-Based Live Attenuated Vaccine Completely Protects Chickens and Mice from Lethal Challenge of Homologous and Heterologous H5N1 Avian Influenza Viruses
  Journal of Virology, 2007
• Live, Attenuated Influenza A H5N1 Candidate Vaccines Provide Broad Cross-Protection in Mice and Ferrets
  PLoS Medicine, 2006
• Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial
  The Lancet, 2006
• Lack of transmission of H5N1 avian–human reassortant influenza viruses in a ferret model
  Proceedings of the National Academy of Sciences, 2006
• Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenza
  Proceedings of the National Academy of Sciences, 2006
• The development and characterization of H5 influenza virus vaccines derived from a 2003 human isolate
  Vaccine, 2006
• Immunogenicity of Fowlpox Virus Expressing the Avian Influenza Virus H5 Gene (TROVAC AIV-H5) in Cats
  Clinical and Vaccine Immunology, 2005
• Cross‐Reactivity to Highly Pathogenic Avian Influenza H5N1 Viruses after Vaccination with Nonadjuvanted and MF59‐Adjuvanted Influenza A/Duck/Singapore/97 (H5N3) Vaccine: A Potential Priming Strategy
  The Journal of Infectious Diseases, 2005
• Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza
  The Lancet, 2001
• Recombinant Influenza A Virus Vaccines for the Pathogenic Human A/Hong Kong/97 (H5N1) Viruses
  The Journal of Infectious Diseases, 1999